Yuxin Xie Selected Research

Yuxin Xie Research Topics

Disease

24	Neoplasms (Cancer) 05/2024 - 12/2013
7	Breast Neoplasms (Breast Cancer) 12/2022 - 06/2018
3	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 01/2022
3	Carcinogenesis 11/2022 - 09/2017
2	Ovarian Neoplasms (Ovarian Cancer) 12/2023 - 02/2015
2	Hypoxia (Hypoxemia) 11/2020 - 01/2019
2	Carcinoma (Carcinomatosis) 07/2015 - 02/2015
2	Nasopharyngeal Carcinoma 02/2015 - 12/2013
1	Dehydration (Water Stress) 03/2024
1	Idiopathic Generalized Epilepsy 02/2024
1	Hypertension (High Blood Pressure) 02/2024
1	Squamous Cell Carcinoma of Head and Neck 02/2024
1	Fibrosis (Cirrhosis) 12/2023
1	Hepatocellular Carcinoma (Hepatoma) 10/2023
1	Vasculitis (Vasculitides) 06/2023
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 06/2023
1	Purpura 06/2023
1	Ulcerative Colitis 01/2023
1	Colitis 01/2023
1	Candidiasis (Moniliasis) 01/2023
1	Dysbiosis 01/2023
1	Ischemia 12/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2022
1	Infections 12/2022
1	Peritonitis 12/2022
1	Pneumonia (Pneumonitis) 12/2022
1	Colorectal Neoplasms (Colorectal Cancer) 11/2022
1	Wounds and Injuries (Trauma) 05/2022
1	Hemorrhage 03/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2022
1	Hemangiopericytoma 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Glioma (Gliomas) 01/2022
1	Solitary Fibrous Tumors 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Hypercholesterolemia 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 03/2021
1	Atherosclerosis 01/2021

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2022
3	MicroRNAs (MicroRNA)IBA 12/2023 - 01/2017
2	Messenger RNA (mRNA)IBA 02/2024 - 01/2020
2	formononetinIBA 12/2023 - 10/2023
2	CurcuminIBA 12/2023 - 02/2015
2	Temozolomide (Temodar)FDA LinkGeneric 11/2023 - 01/2022
2	Proanthocyanidins (Procyanidins)IBA 06/2023 - 12/2022
2	Long Noncoding RNAIBA 12/2022 - 01/2018
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 11/2022 - 11/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 03/2021 - 07/2015
2	Phosphotransferases (Kinase)IBA 11/2015 - 12/2013
1	IntegrinsIBA 05/2024
1	CytokinesIBA 05/2024
1	CollagenIBA 05/2024
1	Abscisic AcidIBA 03/2024
1	Immunoglobulin E (IgE)IBA 02/2024
1	Antihypertensive Agents (Antihypertensives)IBA 02/2024
1	Catalytic DNA (Deoxyribozyme)IBA 12/2023
1	PolymersIBA 12/2023
1	Colloids (Colloid)IBA 12/2023
1	ParaffinIBA 09/2023
1	Formaldehyde (Formol)FDA Link 09/2023
1	Immunoglobulins (Immunoglobulin)IBA 06/2023
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Sijunzi decoctionIBA 01/2023
1	antimycinIBA 12/2022
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 12/2022
1	AcidsIBA 12/2022
1	AntioxidantsIBA 12/2022
1	Estrogen ReceptorsIBA 12/2022
1	Proton Pump InhibitorsIBA 12/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2022
1	Deubiquitinating EnzymesIBA 11/2022
1	LipidsIBA 11/2022
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 11/2022
1	DNA (Deoxyribonucleic Acid)IBA 08/2022
1	MetalsIBA 08/2022
1	HydrogelsIBA 05/2022
1	LigninIBA 05/2022
1	Trastuzumab (Herceptin)FDA Link 05/2022
1	human ERBB2 proteinIBA 05/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Transfer RNA (tRNA)IBA 07/2021
1	Vancomycin FDA LinkGeneric 03/2021
1	A 7 (A-7)IBA 01/2021
1	huanglian-jie-du decoctionIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 11/2020
1	phytochlorinIBA 11/2020
1	Oxygen (Dioxygen)IBA 11/2020
1	ceric oxide (cerium dioxide)IBA 11/2020
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 11/2020
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2020

Therapy/Procedure

8	Therapeutics 01/2023 - 02/2015
6	Radiotherapy 11/2022 - 07/2015
4	Immunotherapy 05/2024 - 01/2022
2	Peritoneal Dialysis 12/2022 - 03/2022
1	Drug Therapy (Chemotherapy) 11/2023
1	Neoadjuvant Therapy 01/2022